US Patent Issued to Amgen on Nov. 25 for "Proteins specific for BAFF and B7RP1 and uses thereof" (California, Washington Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,930, issued on Nov. 25, was assigned to Amgen Inc. (Thousand Oaks, Calif.).

"Proteins specific for BAFF and B7RP1 and uses thereof" was invented by Hailing Hsu (Moorpark, Calif.), Ming Zhang (Thousand Oaks, Calif.), Gunasekaran Kannan (Daly City, Calif.), Frederick W. Jacobsen (Newbury Park, Calif.) and Wayne H. Tsuji (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are bispecific proteins specific for BAFF and B7RP1, nucleic acids encoding such proteins, methods of making such proteins, and uses for such proteins."

The patent was filed on Sept. 28, 2022, under Application No. 17/936,062.

*For further information, including...